Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Update: Record increase in number of volunteers boosts 2007 Continence Awareness Week

  • Comment
Continence Awareness Week saw a record increase in support this year.

The number of healthcare professionals who volunteered to display leaflets, posters and stickers in their local communities rose to more than 2,050, up by almost 30% on last year.

The Continence Foundation’s Awareness Week, which took place on 17–23 September this year, is an annual campaign to publicise the professional help available for men and women with bladder or bowel control problems. It also aims to counter the stigma associated with the condition and the myths that prevent people seeking help.

Media coverage included a feature in Top Santé magazine, an article in Woman’s Weekly and coverage on the BBC Interactive community pages, among others. The foundation also took part in a series of radio programmes on the first day of the campaign. Twenty-nine local radio stations from across the UK featured items about continence problems, reaching an estimated total audience of 1.66 million listeners.
Many of the foundation’s supporters organised local publicity activities such as information stands in shopping centres or town halls. By utilising the promotional materials provided in their free campaign pack, a number of them also attracted local media coverage.

For further information about Continence Awareness Week, email aware@continence-foundation.org.uk (including a postal address).

Evidence base remains poor for botulinum toxin injections, Cochrane review researchers conclude

The efficacy of using intravesical botulinum toxin to treat overactive bladder syndrome is supported by little more than anecdotal evidence and case reports, according a Cochrane review. In addition, the optimal dose of botulinum toxin for efficacy and safety has not been identified.

Eight studies were included in the review. Overall, botulinum toxin performed better than placebos in outcomes such
as incontinence episodes, bladder capacity, maximum detrusor pressure and quality of life.

Low doses of botulinum toxin (100U to150U) appeared to have beneficial effects but higher doses (300U) may have been more effective.

The treatment appeared to involve few side-effects or complications but the authors did not identify any long-term follow-up studies.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.